Novel role for receptor dimerization in post-translational processing and turnover of the GR?.
Ontology highlight
ABSTRACT: Glucocorticoids (GCs), acting via the glucocorticoid receptor (GR?), remain the mainstay therapeutic choice for the treatment of inflammation. However, chronic GC use, aside from generating undesirable side-effects, results in GR? down-regulation, often coupled to a decrease in GC-responsiveness, which may culminate in acquired GC resistance. The current study presents evidence for a novel role of the dimerization state of the GR? in mediating GC-mediated GR? turnover. Through comparing the effects of dimerization promoting GCs on down-regulation of a transfected human wild type GR? (hGRwt) or a dimerization deficient GR? mutant (hGRdim), we established that a loss of receptor dimerization restricts GR? turnover, which was supported by the use of the dimerization abrogating Compound A (CpdA), in cells containing endogenous GR?. Moreover, we showed that the dimerization state of the GR? influenced the post-translational processing of the receptor, specifically hyper-phosphorylation at Ser404, which influenced the interaction of GR? with the E3 ligase, FBXW7?, thus hampering receptor turnover via the proteasome. Lastly, the restorative effects of CpdA on the GR? pool, in the presence of Dex, were demonstrated in a combinatorial treatment protocol. These results expand our understanding of factors that contribute to GC-resistance and may be exploited clinically.
SUBMITTER: Wilkinson L
PROVIDER: S-EPMC6155283 | biostudies-literature | 2018 Sep
REPOSITORIES: biostudies-literature
ACCESS DATA